Optimization of acyclovir oral tablets based on gastroretention technology: Factorial design analysis and physicochemical characterization studies

References

• Barakat NS, Elbagory IM, Almurshedi AS. (2009). Controlled-release carbamazepine matrix granules and tablets comprising lipophilic and hydrophilic components. Drug Deliv, 16:57–65.
   PubMed Web of Science ®Google Scholar
• Barhate SD, Patel KM, Rupnar YS. (2009). Formulation optimization of controlled release floating tablets of amoxacillin trihydrate with K-clavulanate. J Pharmacy Res, 2:1471–1474.
   Google Scholar
• Boldhane SB, Kuchekar BS. (2009). Gastroretentive drug delivery system of quetiapine fumarate: formulation and in vitro evaluation using 32 full factorial design. J Pharm Res, 2:1429–1433.
   Google Scholar
• Brijesh SD, Avani FA. (2004). Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS Pharmscitech, 5:34–39.
   Google Scholar
• Chawla G, Bansal A. (2003). A means to address regional variability in intestinal drug absorption. Pharm Technol, 27:50–68.
   Google Scholar
• Chengsheng L, Kashappa G, Xuexi T, Xiguang C. (2006). Drug release kinetics of spray-dried chitosan microspheres. Drying Technol, 24:769–776.
   Web of Science ®Google Scholar
• Dasharath MP, Natavarlal MP, Viral FP, Darshini AB. (2007). Floating granules of ranitidine hydrochloride-gelucire 43/01: formulation optimization using factorial design. AAPS Pharmscitech 8:1–8.
   PubMedGoogle Scholar
• Deshpande AA, Rhodes CT, Shah NH. (1996). Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev Ind Pharm, 22:531–539.
   Web of Science ®Google Scholar
• Deshpande AA, Shah NH, Rhodes CT, Malick W. (1997). Development of a novel controlled-release system for gastric retention. Pharm Res, 14:815–819.
   PubMed Web of Science ®Google Scholar
• Design Expert, Stat-Ease Inc. (2008). (http://www.statease.com/dx8descr.html). Minneapolis, USA.
   Google Scholar
• Dhaliwal S, Jain S, Singh HP, Tiwary AK. (2008). Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation. AAPS J, 10:322–330.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Peppas NA, McGinity JW. (2006). Floating hot-melt extruded tablets for gastroretentive controlled drug release system. J Control Release, 115:121–129.
   PubMed Web of Science ®Google Scholar
• Gambhire MN, Ambade KW, Kurmi SD, Kadam VJ, Jadhav KR. (2007). Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride. AAPS Pharmscitech, 8:E73.
   PubMedGoogle Scholar
• Garg R, Gupta GD. (2009). Preparation and evaluation of gastroretentive floating tablets of Silymarin. Chem Pharm Bull, 57:545–549.
   PubMed Web of Science ®Google Scholar
• Gennaro AR. (2005). Antivirals. In: Remington PJ ( ed.), Remington’s Pharmaceutical Sciences. Mack: Easton, PA, pp. 1675–1677.
   Google Scholar
• Gibaldi M, Feldman S. (1967). Establishment of sink conditions in dissolution rate determinations. Theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci, 56:1238–1242.
   PubMed Web of Science ®Google Scholar
• Gromova LI, Hoichman D, Sela J. (2007). Gastroretentetivesustained release acyclovir tablets based on synergistically interacting polysaccharides. Pharma Chem J, 41:656–659.
   Google Scholar
• Gutiérrez-Sánchez PE, Hernández-León A, Villafuerte-Robles L. (2008). Effect of sodium bicarbonate on the properties of metronidazole floating matrix tablets. Drug Dev Ind Pharm, 34:171–180.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci, 50:874–875.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci, 52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Immordino ML, Brusa P, Rocco F, Arpicco S, Ceruti M, Cattel L. (2004). Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs. J Control Release, 100:331–346.
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Pornsuwannapha S. (2008). Floating properties and release characteristics of hollow microspheres of acyclovir. Drug Deliv, 15:331–341.
   PubMed Web of Science ®Google Scholar
• Kiortsis S, Kachrimanis K, Broussali T, Malamataris S. (2005). Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur J Pharm Biopharm, 59:73–83.
   PubMed Web of Science ®Google Scholar
• Kopcha M, Lordi NG, Tojo KJ. (1991). Evaluation of release from selected thermosoftening vehicles. J Pharm Pharmacol, 43:382–387.
   PubMed Web of Science ®Google Scholar
• Li FQ, Hu JH, Deng JX, Su H, Xu S, Liu JY. (2006). In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets. Int J Pharm, 324:152–157.
   PubMed Web of Science ®Google Scholar
• Lund W. (1994). Pharmaceutical Codex. Pharmaceutical Press: London, pp. 711–713.
   Google Scholar
• Mayur GS, Rajashree CM, Jolly MS. (2007). Reversed chitosan–alginate polyelectrolyte complex for stability improvement of α-amylase: optimization and physicochemical characterization. Eur J Pharm Biopharm, 65:215–232.
   PubMed Web of Science ®Google Scholar
• Menon A, Ritschel WA, Sakr A. (1994). Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci, 83:239–245.
   PubMed Web of Science ®Google Scholar
• Monica RR, Girish SS, Rachana RM, Swapnila DV. (2009). Evaluation of effervescent floating matrix tablet formulations of salbutamol sulfate using full factorial design. Asian J Pharm, 3:43–49.
   Google Scholar
• Patel A, Modasiya M, Shah D, Patel V. (2009). Development and in vivo floating behavior of verapamil HCl intragastric floating tablets. AAPS Pharmscitech, 10:310–315.
   PubMed Web of Science ®Google Scholar
• Patel DM, Patel NM, Pandya NN, Jogani PD. (2007). Formulation and optimization of carbamazepine floating tablets. Ind J Pharm Sci, 69:763–767.
   Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Rel, 5:37–42.
   Google Scholar
• Santus G, Lazzarini G, Bottoni G. (1997). An in vitro-in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm, 44:39–52.
   Web of Science ®Google Scholar
• Sasa BA, Julijana KA, Franc V, Polona V. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 195:125–135.
   PubMed Web of Science ®Google Scholar
• Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139–157.
   PubMed Web of Science ®Google Scholar
• Singh BN, Kim KH. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release, 63:235–259.
   PubMed Web of Science ®Google Scholar
• Srivastava AK, Wadhwa S, Ridhurkar D, Mishra B. (2005). Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation. Drug Dev Ind Pharm, 31:367–374.
   PubMed Web of Science ®Google Scholar
• Strübing S, Metz H, Mäder K. (2008). Characterization of poly(vinyl acetate) based floating matrix tablets. J Control Release, 126:149–155.
   PubMed Web of Science ®Google Scholar
• Stulzer HK, Tagliari MP, Parize AL,Silva MA. (2009). Evaluation of cross-linked chitosan microparticles containing acyclovir obtained by spray-drying. Materials Sci Eng, 29:387–392.
   Web of Science ®Google Scholar
• Sungthongjeen S, Sriamornsak P, Puttipipatkhachorn S. (2008). Design and evaluation of floating multi-layer coated tablets based on gas formation. Eur J Pharm Biopharm, 69:255–263.
   PubMed Web of Science ®Google Scholar
• Tadros MI. (2010). Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur J Pharm Biopharm, 74:332–339.
   PubMed Web of Science ®Google Scholar
• Wagner JG. (1969). Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci, 58:1253–1257.
   PubMed Web of Science ®Google Scholar
• Whitehead L, Fell JT, Collett JH, Sharma HL, Smith A. (1998). Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Release, 55:3–12.
   PubMed Web of Science ®Google Scholar
• Zhao L, Yang X, Xu R, Wu J, Gu S, Zhang L et al. (2009). Safety, tolerability and pharmacokinetics of phenoprolamine hydrochloride floating sustained-release tablets in healthy Chinese subjects. Int J Pharm, 377:99–104.
   PubMed Web of Science ®Google Scholar